Medicare Enrolled

Dr. Khalid Sherani, MD

Pulmonary Disease · Texarkana, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2602 SAINT MICHAEL DR STE 400, Texarkana, TX 75503
9036145670
In practice since 2015 (11 years)
NPI: 1760873293 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sherani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sherani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sherani

Dr. Khalid Sherani is a pulmonary disease in Texarkana, TX, with 11 years in practice. Based on federal Medicare data, Dr. Sherani performed 135 Medicare services across 101 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sherani received a total of $2,262 from 18 pharmaceutical and/or device companies across 30 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sherani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ 135 Medicare services$ $2,262 industry payments

Medicare Practice Summary

Medicare Utilization ↗
135
Medicare services
Bottom 9% in TX for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
101
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity63$91$401
Hospital follow-up visit, moderate complexity33$55$264
Initial hospital admission, moderate complexity26$100$618
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes13$63$425
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,262
Total received (2018-2024)
Avg $323/year across 7 years
Top 46% in TX for pulmonary disease
18
Companies
30
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,372 (60.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$890 (39.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14
2023
$216
2022
$37
2021
$1,169
2020
$256
2019
$402
2018
$167

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Hill-Rom Services, Inc
$875
ABIOMED
$370
Actelion Pharmaceuticals US, Inc.
$205
Genentech USA, Inc.
$138
Janssen Pharmaceuticals, Inc
$132
Paratek Pharmaceuticals, Inc.
$119
GlaxoSmithKline, LLC.
$113
La Jolla Pharmaceutical Company
$100
E.R. Squibb & Sons, L.L.C.
$38
EKOS Corporation
$28
Smith+Nephew, Inc.
$23
Grifols USA, LLC
$23
Melinta Therapeutics, LLC
$22
Melinta Therapeutics, Inc.
$19
Mylan Specialty L.P.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Edwards Lifesciences Corporation
$14
Philips Electronics North America Corporation
$11
Top 3 companies account for 64.1% of total payments
Associated products mentioned in payments ›
(8874) inCourage · Baxdela · EKOSONIC · ELIQUIS · GIAPREZA · Impella · NUZYRA · OPSUMIT · Prolastin-C Liquid · RENASYS GO · STIOLTO RESPIMAT · TRELEGY ELLIPTA · The Monarch Airway Clearance System · Vabomere · XARELTO · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,676 per 100 Medicare services performed
Looking for a pulmonary disease in Texarkana?
Compare pulmonary diseases in the Texarkana area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
6
Per 100K population
6.5
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sherani is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sherani experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Sherani performed 63 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sherani receive payments from pharmaceutical companies?
Yes. Dr. Sherani received a total of $2,262 from 18 companies across 30 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sherani's costs compare to other pulmonary diseases in Texarkana?
Dr. Sherani's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sherani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →